Management of patients with ovarian cancer in the COVID‐19 era. Issue 2 (31st May 2020)

• Record Type: Journal Article
• Authors: Bogani, Giorgio; Casarin, Jvan; Pinelli, Ciro; Di Donato, Violante; Bosio, Sara; Ruisi, Simona; Brusadelli, Claudia; Guerrisi, Rocco; Sarpietro, Giuseppe; Ditto, Antonino; Ghezzi, Fabio; Raspagliesi, Francesco
• Is Part Of: Journal of surgical oncology. Volume 122:Issue 2(2020)
• Page Start: 122
• Page End: 123
• Publication Date: 2020-05-31
• Subjects: chemotherapy -- COVID‐19 -- ovarian cancer -- SARS‐CoV -- surgery; Cancer -- Surgery -- Periodicals; Neoplasms -- Periodicals; 616
• DOI: 10.1002/jso.26057
• Languages: English
• ISSNs: 0022-4790

Abstract

Abstract: At the beginning of 2020, coronavirus disease 2019 (COVID‐19) spreads worldwide. Patients with ovarian cancer should be considered at high‐risk of developing severe morbidity related to COVID‐19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID‐19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment.